Medindia

X

Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting

Friday, November 14, 2008 General News J E 4
Advertisement
KING OF PRUSSIA, Pa., Nov. 13 The Board of Directors ofTunnell Consulting, Inc. today announced that Conrad J. Heilman, Ph.D., willsucceed Joseph S. Tempio, Ph.D. as President and Chief Executive Officer,effective July 2009. Heilman will serve immediately as Chief Operating Officerand retain that post until he becomes President and CEO.

Heilman currently serves as Senior Vice President of the Life SciencesStrategic Operating Unit (SOU) with responsibility for the entire SOUincluding the firm's offices in King of Prussia, California, and Puerto Rico.Since joining the firm in 2000 as a Managing Consultant, he has played anincreasingly important role. He spearheaded multi-million dollar projects forrespected international firms and partnered with key clients to develop andimplement initiatives to improve operational performance and regulatorycompliance. Heilman was instrumental in securing a contract with the NationalInstitutes of Health (NIH) and a five-year $32 million dollar contract withthe Department of Health and Human Services (HHS) to support the federalgovernment's pandemic flu preparedness initiative.

"Conrad has had a tremendous impact on Tunnell and has done an excellentjob of building our Life Sciences Strategic Operating Unit. His vision andwillingness to take risks has extended our reach into the public sector withhis initial involvement with HHS," said Tempio, who will continue as Chairmanand will work closely with Heilman to ensure a smooth transition to Presidentand CEO. "Conrad is a natural leader whose accomplishments in research,development, manufacturing, and regulatory issues make him ideally suited tomanaging Tunnell. The Board is confident that he will do a superb job inrepresenting the firm to its clients and in providing them with exemplaryservice and innovative solutions to their most complex problems."

Prior to Tunnell, Heilman held senior positions in a number of companies.He was President of Quality Biotech Inc., Vice President of Research for Pro-Virus, a Director of Applied Biotechnology at DuPont Merck Pharmaceutical Co.,and held other managerial and research positions for E.I. DuPont De Nemours,American Cyanamid, and Litton Bionetics.

Heilman's educational background in life sciences is extensive. A graduateof Long Island University with a B.S. degree in Biology, he earned his M.S.degree in Immunology from the University of Pennsylvania, and a Ph.D. inPathobiology from Johns Hopkins University. He has published numerousarticles in peer-reviewed journals and has a number of issued patents.

"Joe Tempio has guided the firm through one of its greatest growth periodsand nurtured an environment that has driven profitability," Heilman said.

In 1999 Tempio joined Tunnell as head of a new practice - Life SciencesTechnical Services. Under his direction, the unit experienced a steady andhealthy growth, and in 2004 Tunnell adopted a new strategy to focus onconsulting exclusively in life sciences. To spur more growth, Tempiorestructured the organization into three strategic operating units. One of theunits he established was a Government Services operating unit with offices inBethesda. Md.- which serves the life sciences segments of the federalgovernment. In 2006, Tempio expanded operations by opening offices in SanDiego and San Juan, Puerto Rico to better serve the unique needs of the lifesciences community. Between 2004 - the year Tempio was appointed Presidentand CEO - and 2008, Tunnell expects revenues will have increased by almost 100percent.

"It is with great honor, excitement, and enthusiasm that I take on thisnew role and responsibilities of leading Tunnell as it moves forward to a newphase of growth and development," said Heilman. "As we continue to grow andexpand in other areas, we also realize that the life sciences industry is at acrossroads, with unprecedented changes. With increased competition amongpharmaceutical companies, soaring health care costs, safety and patientissues, the climate is challenging but also offers exciting opportunities forthe firm. With our depth of experience and focus in the life sciences, Tunnellis uniquely positioned to respond and adapt to the changing environment andhelp our clients solve their most complex problems."

About Tunnell Consulting

King of Prussia, PA-based Tunnell Consulting integrates strategic,technical, process and organizational skills to boost its clients' businessperformance. Founded in 1962, Tunnell focuses on the life sciences industryand government agencies, designing and implementing sustainable solutions thatimprove operating performance. The firm draws on the expertise of itsaccomplished multi-disciplinary professionals with experience in industry,government and research. Working with many of the world's leading companiesand the public sector, Tunnell implements value-added, cost-effectivesolutions that fit the unique needs of each client they serve. Moreinformation may be found at www.tunnellconsulting.com.

SOURCE Tunnell Consulting
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pharmaceutical Industry Needs to Speed Up Transfor...
S
Cord Blood America Posts Letter to Shareholders: N...